These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6463359)

  • 1. [Therapy modalities used in tuberculosis in a French Department. The Bas-Rhin, 1965-77].
    Burghard G; Lotte A; Petitjean R; Rempp M
    Rev Mal Respir; 1984; 1(2):85-91. PubMed ID: 6463359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitubercular therapeutic regimens routinely prescribed in Bas-Rhin and results of treatment].
    Liard R; Perdrizet S; Burghard G; Petitjean R; Rempp M; Pierau F; Chenuet J
    Rev Mal Respir; 1986; 3(2):93-7. PubMed ID: 3726265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiologic study of the risk of tuberculosis recurrence in the Bas-Rhin, 1967-77].
    Petitjean R; Lert F; Lotte A; Burghard G
    Rev Mal Respir; 1984; 1(2):93-7. PubMed ID: 6463360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Respiratory tuberculosis in Seine-Saint-Denis. Results of treatment].
    Lepetit C; Thebaud-Mony A
    Rev Mal Respir; 1989; 6(5):451-6. PubMed ID: 2602618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Time trend in incidence and mortality of tuberculosis and characteristics of notified tuberculosis patients in urban area of Mongolia].
    Toyota M
    Kekkaku; 1998 Jul; 73(7):477-83. PubMed ID: 9739580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment modalities applied to tuberculosis patients in a French department. Hautes-Pyrénées, 1973 to 1980].
    Hetrick G; Humarau H
    Rev Fr Mal Respir; 1983; 11(6):883-7. PubMed ID: 6669799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
    Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of knowledge on the treatment of tuberculosis and therapy prescribed in all new cases of pulmonary tuberculosis in a French community since 1970].
    Liard R; Perdrizet S; Burghard G; Pierau F; Rempp M; Chenuet J
    Rev Epidemiol Sante Publique; 1983; 31(3):299-309. PubMed ID: 6658104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic modalities applied to tuberculotics in the Rhône Department in 1982].
    Harf R; Lechemia D
    Rev Pneumol Clin; 1987; 43(5):229-35. PubMed ID: 3432864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tuberculosis in France. Current epidemiologic status and evolution over the last 10 years].
    Perdrizet S; Liard R; Berbar T; Poisson N
    Rev Fr Mal Respir; 1983; 11(5):687-97. PubMed ID: 6658155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
    J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of the standard regimen for initial treatment of pulmonary tuberculosis: results of long-term followed-up].
    Wada M; Yoshiyama T; Sugie T; Nakazono T; Ogata H; Sugita H
    Kekkaku; 1994 Apr; 69(4):301-6. PubMed ID: 8189683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the treatment of urogenital tuberculosis].
    Lipsky H; Stadler W
    Wien Klin Wochenschr; 1988 Sep; 100(17):573-6. PubMed ID: 3188530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of tuberculosis in France].
    Dautzenberg B
    Rev Pneumol Clin; 1994; 50(5):256-9. PubMed ID: 7899759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.